Standout Papers
Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
2011
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
2011 Standout
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
2008
Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between FcγRI and FcγRIV
2008
Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer
2004
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
The challenges faced in the design, conduct and analysis of surgical randomised controlled trials
2009
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Gastric cancer
2016 Standout
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
2008
Multimodal approach to control postoperative pathophysiology and rehabilitation
1997 Standout
Risk factors for surgical treatment in the Dutch gastric cancer trial
1997
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer
2001
Omental milky spots in the local immune response in the peritoneal cavity of rats
1996
Preferential Attachment of Peritoneal Tumor Metastases to Omental Immune Aggregates and Possible Role of a Unique Vascular Microenvironment in Metastatic Survival and Growth
2006
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
2004
Irinotecan in the treatment of gastric cancer
2003
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
2014
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
2004
Cytogenetics in acute leukemia
2003
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
2008
Evaluation and stages of surgical innovations
2009 Standout
Does Adjuvant Chemoradiotherapy Improve the Prognosis of Gastric Cancer After an R1 Resection? Results from a Dutch Cohort Study
2014
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
2010 Standout
The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer
2005
Investigation of the recurrence patterns of gastric cancer following a curative resection
2011
Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach
2012
Morbidity and Mortality Following Multivisceral Resections in Complex Hepatic and Pancreatic Surgery
2007
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Gastric cancer—Patterns of relapse after surgical resection
2002
Nodal dissection for patients with gastric cancer: a randomised controlled trial
2006
Chemotherapy for advanced gastric cancer
2010
Chemotherapy for advanced gastric cancer
2005
IgG4‐related disease: Historical overview and pathology of hematological disorders
2010
Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver
2001 StandoutNobel
Improved regional control and survival with “low Maruyama Index” surgery in gastric cancer: autopsy findings from the Dutch D1-D2 Trial
2007
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Morbidity and mortality after D1 and D2 gastrectomy for cancer: Interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial
2003
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016
Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases
2011
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Gastric cancer treatment guidelines in Japan
2002
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Oesophageal carcinoma
2013 Standout
Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial
1996
A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma
2002
Omental Milky Spots Develop in the Absence of Lymphoid Tissue-Inducer Cells and Support B and T Cell Responses to Peritoneal Antigens
2009 Standout
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
2003
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin
2002
Biodefense function of omental milky spots through cell adhesion molecules and leukocyte proliferation
2002
Guidelines for the management of oesophageal and gastric cancer
2011
Gut flora in health and disease
2003 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Ventilator-Induced Lung Injury
2013 Standout
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment
2002
Long-term survival with non-proportional hazards: results from the Dutch Gastric Cancer Trial
2005
Gastric cancer
2020 Standout
Surgery in older patients
2004
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
2009 StandoutNature
Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma
2008
IgG4-related disease
2014 Standout
Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma
2005
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Improved survival after resectable non-cardia gastric cancer in the Netherlands: The importance of surgical training and quality control
2009
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis
2003
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Updates on esophageal and gastric cancers
2006
Transhiatal Esophagectomy: Clinical Experience and Refinements
1999
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2013
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
2002
Idiopathic Chronic Pancreatitis With Periductal Lymphoplasmacytic Infiltration
2003
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach
2005
Macrophages direct tumour histology and clinical outcome in a colon cancer model
2005
The Reporting of Randomized Clinical Trials Using a Surgical Intervention Is in Need of Immediate Improvement
2006
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
2007
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Chlorhexidine–Alcohol versus Povidone–Iodine for Surgical-Site Antisepsis
2010 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial
1999 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Adverse Ventilatory Strategy Causes Pulmonary-to-Systemic Translocation of Endotoxin
2000
Gastric Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations
1996
Low Maruyama Index Surgery for Gastric Cancer: Blinded Reanalysis of the Dutch D1‐D2 Trial
2005
Randomized clinical trial of single- versus multiple-dose antimicrobial prophylaxis in gastric cancer surgery
2007
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Quality control of lymph node dissection in the Dutch Gastric Cancer Trial
2015
EBV-Positive Gastric Adenocarcinomas: A Distinct Clinicopathologic Entity With a Low Frequency of Lymph Node Involvement
2004
The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.
2000
Omental Milky Spots and Peritoneal Dialysis — Review and Personal Experience
2005
Chemotherapy for advanced gastric cancer
2017 Standout
Disparities in Gastric Cancer Chemotherapy Between the East and West
2006
The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy
2000
Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial
2004
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
2000
Optimal Locoregional Treatment in Gastric Cancer
2005
Manipulation of local and systemic host defence in the prevention of perioperative sepsis
1995
Omental Milky Spots in Peritoneal Pathophysiology (Spots before your Eyes)
2005
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Endotoxin Down-Regulates T Cell Activation by Antigen-Presenting Liver Sinusoidal Endothelial Cells
1999
Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501
2004
Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer
2013
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
1999
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer
2010
Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
2010
Works of Sybren Meyer being referenced
Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon ?
1994
Cellular composition of milky spots in the human greater omentum: An immunochemical and ultrastructural study
1995
Extended Lymph-Node Dissection for Gastric Cancer
1999 Standout
Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma
1993
Ontogeny of milky spots in the human greater omentum: An immunochemical study
1997
Milky spots in the greater omentum are predominant sites of local tumour cell proliferation and accumulation in the peritoneal cavity
1998
Novel isolation and purification method permitting functional cytotoxicity studies of macrophages from milky spots in the greater omentum
1995
Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells
1993
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients
1995
Occlusive Phlebitis in Multifocal Fibrosclerosis
1976
Clinical significance of translocation.
1994